Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
GENELABS TECHNOLOGIES INC /CAListing unverified | AwardD (derivative) | $5K | SEC | ||
GENELABS TECHNOLOGIES INC /CAListing unverified | AwardD (derivative) | $1.7K | SEC | ||
GENELABS TECHNOLOGIES INC /CAListing unverified | AwardD (derivative) | $2.2K | SEC | ||
GENELABS TECHNOLOGIES INC /CAListing unverified | AwardD (derivative) | $6.6K | SEC | ||
GENELABS TECHNOLOGIES INC /CAListing unverified | AwardD (derivative) | $26.4K | SEC | ||
GENELABS TECHNOLOGIES INC /CAListing unverified | AwardD (derivative) | $12.6K | SEC | ||
GENELABS TECHNOLOGIES INC /CAListing unverified | AwardD (derivative) | $37.8K | SEC | ||
GENELABS TECHNOLOGIES INC /CAListing unverified | Buy | $16.7K | conv 49First in 12mo | SEC |